Demographic and clinical data
| Pt No. | Age (y)/Sex | TNM Staging | Tumor Response | PFS |
|---|---|---|---|---|
| 1 | 40/M | T3N2aM0 | PR | 6 |
| 2 | 34/M | T4N2cM0 | PR | 14 |
| 3 | 57/M | T4N1M0 | SD | 6 |
| 4 | 59/M | T4N2cM0 | SD | 12 |
| 5 | 45/M | T4N3M0 | PR | 11 |
| 6 | 55/F | T4N2bM0 | PR | 24 |
| 7 | 59/M | T4N3M0 | SD | 4 |
| 8 | 62/M | T4N2cM0 | SD | 24 |
| 9 | 61/M | T4N3M0 | SD | 14 |
| 10 | 47/M | T4N2cM0 | PR | 15 |
| 11 | 72/M | T4N3M0 | PR | 6 |
| 12 | 49/M | T4N2cM0 | SD | 8 |
| 13 | 57/M | T4N2cM0 | PR | 8 |
| 14 | 64/M | T4N1M0 | PR | 4 |
| 15 | 53/M | T4N2cM0 | SD | 11 |
| 16 | 56/M | T4N3M0 | SD | 5 |
| 17 | 62/F | T4N2cM0 | PR | 10 |
| 18 | 65/M | T4N3M0 | PR | 13 |
| 19 | 59/M | T4N2cM0 | PR | 12 |
Note:—TNM indicates tumors, nodes, and metastasis; PR indicates partial response; SD, stable disease; PFS, progression-free survival (in months).